![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Hadassah Medical Organization |
---|---|
Information provided by: | Hadassah Medical Organization |
ClinicalTrials.gov Identifier: | NCT00294489 |
A relatively large proportion of patients with chronic HCV infection have normal or mildly elevated ALT. Many of these patients are not being treated, and are not being sent for a liver biopsy. The present study will determine the ability of Methcetin BreathID Test(MBIT) to detect those patients who will be candidates for anti-viral treatment, as an alternative measure for liver biopsy in decision-making prior to treatment in clinical hepatology.
Study Type: | Observational |
Study Design: | Natural History, Longitudinal, Defined Population, Prospective Study |
Official Title: | Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT |
Estimated Enrollment: | 500 |
Study Start Date: | February 2006 |
Estimated Study Completion Date: | December 2006 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Gadi Lalazar, MD | 00 972 6778511 | lalazar@hadassah.org.il |
Contact: Arik Tzukert, DMD | 00 972 2 6776095 | arik@hadassah.org.il |
Israel | |
Hadassah Medical Organization | Recruiting |
Jerusalem, Israel, 91120 | |
Contact: Arik Tzukert, DMD 00 972 2 6776095 arik@hadassah.org.il | |
Contact: Hadas Lemberg, PhD 00 972 2 6777572 lhadas@hadassah.org.il | |
Principal Investigator: Gadi Lalazar, MD | |
Sub-Investigator: Tiberiu Hershcovici, MD |
Principal Investigator: | Gadi Lalazar, MD | Hadassah Medical Organization, Jerusalem, Israel |
Study ID Numbers: | ORHCV1-HMO-CTIL |
Study First Received: | February 21, 2006 |
Last Updated: | February 21, 2006 |
ClinicalTrials.gov Identifier: | NCT00294489 |
Health Authority: | United States: Food and Drug Administration; Israel: Israeli Health Ministry Pharmaceutical Administration |
HCV Fibrosis Breath test |
Virus Diseases Hepatitis Liver Diseases Digestive System Diseases Hepatitis, Chronic |
Fibrosis Hepatitis, Viral, Human Hepatitis C Hepatitis C, Chronic |
RNA Virus Infections Flaviviridae Infections Infection |